SEC Form 4 · accession 0001144204-18-018909
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark C Miller
Director
Period of report
Apr 1, 2018
Accepted (ET)
Apr 3, 2018 · 3:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $22.85 | Apr 1, 2018 | A | 9,476 | A | — | Apr 1, 2028 | Common Stock | 9,476 | 9,476 | D |
Explanation of responses
- F1The option vests in 12 equal monthly installments, with the first installment vesting on May 1, 2018.